Good At

Standardized diagnosis and treatment plan development for common andrology diseases (male infertility, male sexual dysfunction, male reproductive endocrine, male adolescent development-related problems, prostate diseases, male fertility preservation) and difficult miscellaneous diseases.

Introduction

Chief physician, MD, doctoral supervisor of the Department of Urology and Andrology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, editor-in-chief of China Journal of Andrology. He is currently the vice president of the China Sexology Society, president of the Shanghai City Education Association, and a member of the standing committee of the three major domestic andrology societies (Andrology Branch of the Chinese Medical Association, Andrology Branch of the Chinese Society of Traditional Chinese Medicine, and Andrology Branch of the China Society of Integrated Traditional Chinese and Western Medicine). He has been engaged in basic and clinical research on andrology diseases for nearly 30 years, covering male infertility, sexual dysfunction, male reproductive endocrine, prostate diseases, etc. He has done a lot of exploratory work in basic and clinical research on andrology diseases. Rich experience in diagnosis and treatment of diseases. Participated in the compilation of diagnosis and treatment guidelines and expert consensus for andrology diseases organized by university associations across the country for many times, and took the lead in putting forward some academic views at home and abroad, such as the concept of "basic treatment of male infertility";"Sequential regulation of male reproductive endocrine targets in andrology, especially clinical application in patients with hypogonadism";"For some patients with prostate hyperplasia combined with hypogonadism, 5a reductase and androgen supplementation can be used in combination", etc., it was the first in China to report the treatment of premature ejaculation with sipulmonil and Zoloft; proposed the continuous application of low-dose PDE5 inhibitors to treat refractory psychogenic ED; studied and discussed the distribution characteristics of traditional Chinese medicine syndromes and medication characteristics of male infertility; published more than 100 articles in foreign SCI and domestic core journals with the first author and corresponding author.